Increased Expression of 5-Lipoxygenase In Glioblastoma Multiforme
- 138 Downloads
Gliomas are the most common primary brain tumors and account for 40% of all central nervous system neoplasms. Glioblastoma multiforme (GBM) is the most malignant glioma and is characterized by highly infiltrative and neurologically destructive growth patterns. Despite new advances in surgical intervention, radiotherapy, chemotherapy, and a variety of molecular target specific therapies, the median survival of patients with GBM did not change in the last two decades. Today, most GBM patients still die in less than a year . Therefore, it is essential to identify novel molecular targets that may be suitable for treatment and prevention of GBM.
KeywordsMalignant Glioma Glioblastoma Multiforme Malignant Mesothelioma Central Nervous System Neoplasm Human Brain Tumor
Unable to display preview. Download preview PDF.
- 2.Ledwozyw A, Lutnicki K: Phospholipids and fatty acids in human brain tumors. Acta Physiol Hungarica 1992; 79:381–387.Google Scholar
- 9.Tong W-g, Ding X-Z, Witt RC, Adrian TE: Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway. Mol Cancer Therap 2002; 1:929–935.Google Scholar
- 14.Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HP: Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exper Therap 1992;261:1143–1146.Google Scholar
- 18.Park YS, Lee JH, Barnett GH, Bondar J, Harwalkar JA, Safayhi H, Golubic M: Frankincense-derived boswellic acids inhibit growth and motility of brain tumor cells. Complementary Therapies Med 2002; 10:117–118.Google Scholar
- 22.Nielsen CK, Ohd JF, Sjolander A: The leukotriene receptor CysLT1 and 5-lipoxygenase are upregulated in colon cancer. In Advances in Prostaglandin, Leukotriene and Other Bioactive Lipid Research: Basic Science and Clinical Applicaions, 2003, Kluwer Academic Plenum Publishers, New York (in press).Google Scholar